Clinical trial Recruiting at 16 sites Observational Ages 18 and up

Using RevCore Catheter to Treat Stent Blockages

Official title: RevCore for In Stent Thrombosis (REVIT)

Run by Inari Medical · NCT06394739 · Data updated 2026-11-12

This study is testing whether the RevCore Catheter can help people with blood clots in their stents in the legs feel better.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorInari Medical
Industry-sponsored
Locations17 sites (New Haven, Connecticut and 16 other locations)
StatusRecruiting
StartedSeptember 9, 2024
Main results expectedApril 2027
Study endsApril 2028
Registry record updatedOctober 27, 2026
Trial IDNCT06394739 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with thrombosed stents located in specific deep vein segments of the lower extremities.

Probably not a fit

Patients with severely damaged stents, bilateral in-stent thrombosis, or certain medical contraindications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to gather data on the effectiveness of the RevCore Thrombectomy Catheter in treating in-stent thrombosis, which occurs when blood clots form within stents. The study will observe patients who have experienced stent blockages in specific deep vein segments of the lower extremities. Participants will be monitored to assess the catheter's performance and outcomes related to the treatment of these blockages. The study is observational, meaning it will collect data without altering the standard treatment protocols.

Why it matters

Potential benefit: If successful, this study could improve treatment options for patients suffering from stent blockages, potentially leading to better outcomes and reduced complications.

How similar studies have gone: While this approach is being evaluated in this specific context, similar thrombectomy techniques have shown promise in treating vascular blockages in other studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years
2. Patients with stent age \> 6 weeks
3. Location of thrombosed stents in proximal lower extremity deep vein segments including at least common femoral, external iliac, or common iliac vein
4. RevCore Thrombectomy Catheter must enter vasculature
5. Willing and able to provide informed consent

Exclusion Criteria:

1. Exposed stents with broken struts, significantly deformed struts, struts protruding into the vessel
2. Stents not wall apposed
3. Stents compressed to \<10mm
4. Bilateral in-stent thrombosis
5. Congenital anatomic anomalies of the iliac veins
6. Allergy, hypersensitivity, or thrombocytopenia from heparin or iodinated contrast agents, except for mild to moderate contrast allergies for which pretreatment can be used
7. Any contraindication to anticoagulants or antiplatelets that, in the opinion of the Investigator, cannot be medically managed throughout the study period
8. Chronic non-ambulatory status
9. Known hypercoagulable states (e.g. antiphospholipid syndrome) that, in the opinion of the Investigator, cannot be medically managed throughout the study period
10. Inability to secure venous access
11. Subject has any condition for which, in the opinion of the Investigator, participation would not be in the best interest of the subject
12. Current participation in another investigational drug or device treatment study

Where it's running

  • Yale University
    New Haven, Connecticut, United States
    Recruiting
  • Medstar Health Research Institute
    Washington D.C., District of Columbia, United States
    Recruiting
  • St. Luke's Hospital Boise
    Boise, Idaho, United States
    Recruiting
  • University of Maryland
    Baltimore, Maryland, United States
    Recruiting
  • New York University- Langone
    New York, New York, United States
    Recruiting
  • Mission Health
    Asheville, North Carolina, United States
    Recruiting
Show 11 more locations
  • UH Cleveland Medical Center
    Cleveland, Ohio, United States
    Recruiting
  • Ohio State University
    Columbus, Ohio, United States
    Recruiting
  • University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting
  • Allegheny Health Network Research Institute
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Spartanburg Medical Center
    Spartanburg, South Carolina, United States
    Recruiting
  • El Paso Cardiology Associates
    El Paso, Texas, United States
    Recruiting
  • Baylor Scott & White Research Institute
    Plano, Texas, United States
    Recruiting
  • Sentara
    Norfolk, Virginia, United States
    Recruiting
  • University of Washington
    Seattle, Washington, United States
    Recruiting
  • West Virginia University- Ruby Memorial
    Morgantown, West Virginia, United States
    Recruiting
  • Thomas Jefferson University
    Philadelphia, Pennsylvania, United States
    Withdrawn

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.